Finch: Finch Therapeutics Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024

Finch Therapeutics Group, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 3.88 million compared to USD 62.35 million a year ago. Basic loss per share from continuing operations was USD 2.41 compared to USD 39.19 a year ago. Diluted loss per share from continuing operations was USD 2.41 compared to USD 39.19 a year ago.